 | • レポートコード：QYR2104Z1038 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、滑液包炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗生物質、鎮痛薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・滑液包炎治療の市場動向 ・企業の競争状況、市場シェア ・滑液包炎治療の種類別市場規模（コルチコステロイド、抗生物質、鎮痛薬、その他） ・滑液包炎治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア） ・滑液包炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・滑液包炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・滑液包炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・滑液包炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・滑液包炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva Pharmaceutical、Crecent Therapeutics、Arinna Lifesciences Private、Sun Pharmaceutical Industries、Bioanalytical Systems、Perrigo Company、Arbor Pharmaceuticals） ・結論 |
Bursitis is a swelling or inflammation of the bursa – a sac filled with a lubricating fluid and located between the tissues such as bone, skin, tendons and muscles. Lubricating fluid helps in reducing the friction, rubbing and irritation upon movement of a joint. Bursitis affects mainly elbow, hip, shoulder, knee and Achilles tendon. The most common symptoms of bursitis are pain, swelling and stiffness in affected area. Sudden or severe pain may gradually build up, if there is a presence of calcium deposits. Bursitis is commonly caused by the repetitive trauma of injuries on the affected area. Improper posture at home, work and poor stretching before exercise also lead to bursitis. A poorly or an abnormal placed bone or joint can put extra stress on a bursa sac, causing bursitis. Infection from other conditions such as thyroid disorder gout, or unusual medication reactions also increase a person’s risk for bursitis. Sometimes an infection can sometimes lead to inflammation of a bursa. In adults bursitis is very common especially those over 40 years of age. There are number of ways for bursitis treatment like resting the injured area, icing the area, avoiding activities that aggravate the problem, taking over the counter anti-inflammatory medicines and many more. Surgery may be an option when bursitis does not respond to the other treatment options but it is rarely needed.
The global bursitis treatment market is driven by the increasing geriatric population highly prone to the bone injury. Another factor which can influence the growth of global bursitis market can be rising number of sports related injuries. Moreover, increasing incidence of elbow joint pain and R&D investment by pharmaceutical companies etc. are the factors which are driving the global bursitis market. However, lack of awareness towards bursitis treatment options, low treatment rate due to absence of signs and symptoms of bursitis are some factors limiting the growth of global bursitis treatment market.
Market Analysis and Insights: Global Bursitis Treatment Market
The global Bursitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bursitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bursitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bursitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bursitis Treatment market.
Global Bursitis Treatment Scope and Market Size
Bursitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bursitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Corticosteroids
Antibiotic
Analgesics
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Teva Pharmaceutical
Crecent Therapeutics
Arinna Lifesciences Private
Sun Pharmaceutical Industries
Bioanalytical Systems
Perrigo Company
Arbor Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bursitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Antibiotic
1.2.4 Analgesics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bursitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bursitis Treatment Market Perspective (2016-2027)
2.2 Bursitis Treatment Growth Trends by Regions
2.2.1 Bursitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bursitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bursitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bursitis Treatment Industry Dynamic
2.3.1 Bursitis Treatment Market Trends
2.3.2 Bursitis Treatment Market Drivers
2.3.3 Bursitis Treatment Market Challenges
2.3.4 Bursitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bursitis Treatment Players by Revenue
3.1.1 Global Top Bursitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Bursitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bursitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bursitis Treatment Revenue
3.4 Global Bursitis Treatment Market Concentration Ratio
3.4.1 Global Bursitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bursitis Treatment Revenue in 2020
3.5 Bursitis Treatment Key Players Head office and Area Served
3.6 Key Players Bursitis Treatment Product Solution and Service
3.7 Date of Enter into Bursitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bursitis Treatment Breakdown Data by Type
4.1 Global Bursitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bursitis Treatment Forecasted Market Size by Type (2022-2027)
5 Bursitis Treatment Breakdown Data by Application
5.1 Global Bursitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bursitis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bursitis Treatment Market Size (2016-2027)
6.2 North America Bursitis Treatment Market Size by Type
6.2.1 North America Bursitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Bursitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Bursitis Treatment Market Size by Type (2016-2027)
6.3 North America Bursitis Treatment Market Size by Application
6.3.1 North America Bursitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Bursitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Bursitis Treatment Market Size by Application (2016-2027)
6.4 North America Bursitis Treatment Market Size by Country
6.4.1 North America Bursitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Bursitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bursitis Treatment Market Size (2016-2027)
7.2 Europe Bursitis Treatment Market Size by Type
7.2.1 Europe Bursitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bursitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bursitis Treatment Market Size by Type (2016-2027)
7.3 Europe Bursitis Treatment Market Size by Application
7.3.1 Europe Bursitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bursitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bursitis Treatment Market Size by Application (2016-2027)
7.4 Europe Bursitis Treatment Market Size by Country
7.4.1 Europe Bursitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bursitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bursitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bursitis Treatment Market Size by Type
8.2.1 Asia-Pacific Bursitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bursitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bursitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bursitis Treatment Market Size by Application
8.3.1 Asia-Pacific Bursitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bursitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bursitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bursitis Treatment Market Size by Region
8.4.1 Asia-Pacific Bursitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bursitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bursitis Treatment Market Size (2016-2027)
9.2 Latin America Bursitis Treatment Market Size by Type
9.2.1 Latin America Bursitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bursitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bursitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Bursitis Treatment Market Size by Application
9.3.1 Latin America Bursitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bursitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bursitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Bursitis Treatment Market Size by Country
9.4.1 Latin America Bursitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bursitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bursitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bursitis Treatment Market Size by Type
10.2.1 Middle East & Africa Bursitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bursitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bursitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bursitis Treatment Market Size by Application
10.3.1 Middle East & Africa Bursitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bursitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bursitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bursitis Treatment Market Size by Country
10.4.1 Middle East & Africa Bursitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bursitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Details
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Bursitis Treatment Introduction
11.1.4 Teva Pharmaceutical Revenue in Bursitis Treatment Business (2016-2021)
11.1.5 Teva Pharmaceutical Recent Development
11.2 Crecent Therapeutics
11.2.1 Crecent Therapeutics Company Details
11.2.2 Crecent Therapeutics Business Overview
11.2.3 Crecent Therapeutics Bursitis Treatment Introduction
11.2.4 Crecent Therapeutics Revenue in Bursitis Treatment Business (2016-2021)
11.2.5 Crecent Therapeutics Recent Development
11.3 Arinna Lifesciences Private
11.3.1 Arinna Lifesciences Private Company Details
11.3.2 Arinna Lifesciences Private Business Overview
11.3.3 Arinna Lifesciences Private Bursitis Treatment Introduction
11.3.4 Arinna Lifesciences Private Revenue in Bursitis Treatment Business (2016-2021)
11.3.5 Arinna Lifesciences Private Recent Development
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Details
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Bursitis Treatment Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Bursitis Treatment Business (2016-2021)
11.4.5 Sun Pharmaceutical Industries Recent Development
11.5 Bioanalytical Systems
11.5.1 Bioanalytical Systems Company Details
11.5.2 Bioanalytical Systems Business Overview
11.5.3 Bioanalytical Systems Bursitis Treatment Introduction
11.5.4 Bioanalytical Systems Revenue in Bursitis Treatment Business (2016-2021)
11.5.5 Bioanalytical Systems Recent Development
11.6 Perrigo Company
11.6.1 Perrigo Company Company Details
11.6.2 Perrigo Company Business Overview
11.6.3 Perrigo Company Bursitis Treatment Introduction
11.6.4 Perrigo Company Revenue in Bursitis Treatment Business (2016-2021)
11.6.5 Perrigo Company Recent Development
11.7 Arbor Pharmaceuticals
11.7.1 Arbor Pharmaceuticals Company Details
11.7.2 Arbor Pharmaceuticals Business Overview
11.7.3 Arbor Pharmaceuticals Bursitis Treatment Introduction
11.7.4 Arbor Pharmaceuticals Revenue in Bursitis Treatment Business (2016-2021)
11.7.5 Arbor Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bursitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Antibiotic
Table 4. Key Players of Analgesics
Table 5. Key Players of Others
Table 6. Global Bursitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bursitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bursitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bursitis Treatment Market Share by Regions (2016-2021)
Table 10. Global Bursitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bursitis Treatment Market Share by Regions (2022-2027)
Table 12. Bursitis Treatment Market Trends
Table 13. Bursitis Treatment Market Drivers
Table 14. Bursitis Treatment Market Challenges
Table 15. Bursitis Treatment Market Restraints
Table 16. Global Bursitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bursitis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Bursitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bursitis Treatment as of 2020)
Table 19. Ranking of Global Top Bursitis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bursitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bursitis Treatment Product Solution and Service
Table 23. Date of Enter into Bursitis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bursitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bursitis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Bursitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bursitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bursitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bursitis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Bursitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bursitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bursitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bursitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bursitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bursitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bursitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bursitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bursitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bursitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bursitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bursitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bursitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bursitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bursitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bursitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bursitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bursitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bursitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bursitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bursitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bursitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bursitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bursitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bursitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bursitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bursitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bursitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bursitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bursitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bursitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bursitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Teva Pharmaceutical Company Details
Table 64. Teva Pharmaceutical Business Overview
Table 65. Teva Pharmaceutical Bursitis Treatment Product
Table 66. Teva Pharmaceutical Revenue in Bursitis Treatment Business (2016-2021) & (US$ Million)
Table 67. Teva Pharmaceutical Recent Development
Table 68. Crecent Therapeutics Company Details
Table 69. Crecent Therapeutics Business Overview
Table 70. Crecent Therapeutics Bursitis Treatment Product
Table 71. Crecent Therapeutics Revenue in Bursitis Treatment Business (2016-2021) & (US$ Million)
Table 72. Crecent Therapeutics Recent Development
Table 73. Arinna Lifesciences Private Company Details
Table 74. Arinna Lifesciences Private Business Overview
Table 75. Arinna Lifesciences Private Bursitis Treatment Product
Table 76. Arinna Lifesciences Private Revenue in Bursitis Treatment Business (2016-2021) & (US$ Million)
Table 77. Arinna Lifesciences Private Recent Development
Table 78. Sun Pharmaceutical Industries Company Details
Table 79. Sun Pharmaceutical Industries Business Overview
Table 80. Sun Pharmaceutical Industries Bursitis Treatment Product
Table 81. Sun Pharmaceutical Industries Revenue in Bursitis Treatment Business (2016-2021) & (US$ Million)
Table 82. Sun Pharmaceutical Industries Recent Development
Table 83. Bioanalytical Systems Company Details
Table 84. Bioanalytical Systems Business Overview
Table 85. Bioanalytical Systems Bursitis Treatment Product
Table 86. Bioanalytical Systems Revenue in Bursitis Treatment Business (2016-2021) & (US$ Million)
Table 87. Bioanalytical Systems Recent Development
Table 88. Perrigo Company Company Details
Table 89. Perrigo Company Business Overview
Table 90. Perrigo Company Bursitis Treatment Product
Table 91. Perrigo Company Revenue in Bursitis Treatment Business (2016-2021) & (US$ Million)
Table 92. Perrigo Company Recent Development
Table 93. Arbor Pharmaceuticals Company Details
Table 94. Arbor Pharmaceuticals Business Overview
Table 95. Arbor Pharmaceuticals Bursitis Treatment Product
Table 96. Arbor Pharmaceuticals Revenue in Bursitis Treatment Business (2016-2021) & (US$ Million)
Table 97. Arbor Pharmaceuticals Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bursitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Antibiotic Features
Figure 4. Analgesics Features
Figure 5. Others Features
Figure 6. Global Bursitis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Bursitis Treatment Report Years Considered
Figure 12. Global Bursitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Bursitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bursitis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Bursitis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Bursitis Treatment Market Share by Players in 2020
Figure 17. Global Top Bursitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bursitis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Bursitis Treatment Revenue in 2020
Figure 19. Global Bursitis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Bursitis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Bursitis Treatment Market Share by Type (2016-2027)
Figure 23. North America Bursitis Treatment Market Share by Application (2016-2027)
Figure 24. North America Bursitis Treatment Market Share by Country (2016-2027)
Figure 25. United States Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bursitis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Bursitis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Bursitis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bursitis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Bursitis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Bursitis Treatment Market Share by Region (2016-2027)
Figure 41. China Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bursitis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Bursitis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Bursitis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bursitis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Bursitis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Bursitis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Bursitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Teva Pharmaceutical Revenue Growth Rate in Bursitis Treatment Business (2016-2021)
Figure 61. Crecent Therapeutics Revenue Growth Rate in Bursitis Treatment Business (2016-2021)
Figure 62. Arinna Lifesciences Private Revenue Growth Rate in Bursitis Treatment Business (2016-2021)
Figure 63. Sun Pharmaceutical Industries Revenue Growth Rate in Bursitis Treatment Business (2016-2021)
Figure 64. Bioanalytical Systems Revenue Growth Rate in Bursitis Treatment Business (2016-2021)
Figure 65. Perrigo Company Revenue Growth Rate in Bursitis Treatment Business (2016-2021)
Figure 66. Arbor Pharmaceuticals Revenue Growth Rate in Bursitis Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の膝蓋前滑液包炎治療市場規模・現状・予測（2021年-2027年） Knee bursitis is inflammation of a small fluid-filled sac (bursa) situated near the knee joint. Bursae reduce friction and cushion pressure points between bones and the tendons, muscles, and skin near joints. Knee bursitis signs and symptoms vary, depending on which bursa is affected and what's caus…- 世界の眼炎症治療市場規模・現状・予測（2021年-2027年） Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the …
- 世界の眼炎症治療市場規模・現状・予測（2021年-2027年） Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the …
- 世界のOTC鎮痛薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global OTC Analgesics Market The global OTC Analgesics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…
- 世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…